Discovered via single-drug scan of fezolinetant. PRR = 11.25 (95% CI 8.06–15.70), n = 34 cases. Pre-reg locked at submission time.
PASSES_ALL_GATES — PRR=11.25 (95% CI 8.06–15.70), n=34 cases; flagged for clinical expert review, NOT for external escalation without manual verification| MedDRA PT | n |
|---|---|
| No reactions surfaced in cohort. | |
Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.
Contact us for verification & validation →b90bf4bb1550e6be58540760138d1dff68e308c6